Buy Tesamorelin – Research Peptide | PEPTEX
44-amino acid synthetic peptide analogue. CAS 218949-48-5. MW 5135.87 Da. Purity ≥98% by HPLC. Carries a trans-3-hexenoic acid moiety conjugated at the N-terminus, increasing resistance to plasma proteases relative to the native sequence. Reconstitute in sterile water. Supplied in a sealed borosilicate glass vial. Intended for laboratory and research use only. Store at −20°C; protect from light and moisture.
Price: EUR | Brand: PEPTEX | In Stock | EU-wide delivery, up to 7 business days
Rating: 4.9/5 (125 reviews)
Customer Reviews
pawel.k — ★★★★★
Third cycle of tesamorelin from peptex. The visceral fat effect is cumulative across cycles. Each one takes me a bit further. Quality is why I keep coming back to the same source.
sam.w — ★★★★★
The visceral fat reduction data is what drew me in. After 16 weeks at 2mg daily, ultrasound showed measurable reduction in visceral adipose tissue. The cognitive clarity was an unexpected bonus. Peptex quality is consistently high.
julien.p — ★★★★★
Running tesamorelin specifically for the visceral fat angle. My abdominal circumference has decreased by 4cm in 14 weeks while my weight barely changed. That's visceral fat being replaced by nothing. Impressive compound, quality source.
Antoine85 — ★★★★★
The GHRH mechanism produces more physiological GH patterns than GHRP alone. My GH labs show natural-looking pulsatile secretion, just amplified. This is what tesa does and peptex version does it well.
Thomas — ★★★★★
my trainer recommended the ipa+tesa stack. ordered both from peptex. the difference in how i feel and recover is night and day compared to just ipamorelin alone. quality of both products is excellent
Available Sizes
- 5mg — 124 EUR
- 10mg — 184 EUR
Storage Recommendations
| Condition | Temperature | Duration |
|---|---|---|
| Lyophilised | -20°C | Up to 24 months |
| Reconstituted | 2-8°C | Up to 12 weeks with Sterile Diluent Solution |
Research References
- Tesamorelin reduces visceral fat in HIV patients (placebo-controlled) — J Clin Endocrinol Metab / PubMed (2010)
- Effect of tesamorelin on visceral fat and liver fat: randomized clinical trial — JAMA / PubMed (2014)
- Tesamorelin — GHRH analogue for HIV-associated lipodystrophy — Expert Opin Pharmacother / PubMed (2011)
💬 Комментарии